DOGE Trading Desk Flows Hint Bottoming. Watch $0.214 Flip for Momentum Trigger
Heavy selling across digital assets drives DOGE 5% lower; desks eye base formation as liquidation pressure shows early signs of exhaustion.
News Background
- DOGE followed the broader market liquidation triggered by renewed U.S.–China tariff rhetoric, sliding 5% from $0.21 highs to settle at $0.20. President Trump’s proposed 100% tariff plan erased roughly $19B in crypto market value, sparking forced liquidations across majors.
- Despite the selloff, institutional desks report accumulation interest near the $0.20 handle as derivatives open interest resets to mid-September levels.
- The House of Doge’s $50M Nasdaq debut through its Brag House Holdings merger continues to underpin long-term institutional narrative, though near-term flows remain risk-off.
Price Action Summary
- DOGE traded a $0.0117 (6%) range between $0.21 and $0.20 through Oct. 14 21:00–Oct. 15 20:00.
- Volume surged to 568.6M at 08:00 on the morning rally to $0.21 before sellers reclaimed control.
- Heaviest liquidation hit 13:00–15:00 window with 920M turnover as price broke below $0.21.
- Capitulation at 19:50 drove price to $0.20 lows on 12M volume, marking likely exhaustion.
- DOGE stabilized near $0.20 into close with reduced volume, hinting early demand return.
Technical Analysis
- Support remains firm around $0.20–$0.202, aligning with high-volume accumulation during liquidation troughs. Resistance stands at $0.21–$0.214, the zone capped by morning reversal volume.
- Short-term structure remains fragile while DOGE trades under the 200-day moving average, but volume compression and stable bid depth at $0.20 suggest potential base-building. A clean reclaim of $0.21 could invite momentum longs targeting $0.224–$0.228.
- Momentum indicators remain oversold; derivative funding turned sharply negative across Binance and OKX — conditions often preceding short-covering rallies.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

STONK hits new highs after erasing 27% crash

25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals
After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.
